Drawing for VERTO

USPTO serial 90416954

VERTO

Reviewed by CopyMark Law Group

Reg. 7724359Status 700Registered
Filing date
Status date
Registration date
Mar 11, 2025
Examiner
ANDERSON, DANIELLE LYNN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VERTO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Craig Fieschko

Craig Fieschko DEWITT LLP2 E. MIFFLIN ST. #600MADISON, WI 53703United States

Goods and services

ClassDescriptionStatusFirst use
042Providing on-line non-downloadable software, Software as a Service (SaaS) services, and Platform as a Service (PAAS) featuring software and computer software platforms for aggregating information from different sources, and presenting summaries thereof, for supporting clinical decisions and healthcare operational intelligence in the healthcare industry; Providing on-line nondownloadable software, Software as a Service (SaaS) services, and Platform as a Service (PAAS) featuring software and computer software platforms for collecting, aggregating and updating patient information; Providing on-line non-downloadable software, Software as a Service (SaaS) services, and Platform as a Service (PAAS) featuring software and computer software platforms for tracking and managing patient health, medical conditions, medical diagnoses, medical treatments, medical appointments, medical reminders, and gaps in medical diagnoses or treatments; Providing on-line nondownloadable software, Software as a Service (SaaS) services, and Platform as a Service (PAAS) featuring software and computer software platforms for administrative, billing, medical, health, and clinical records management, for transmission of records between healthcare providers, and patients, for patient scheduling, for healthcare notifications and reminders, for coordination of care and workloads for use by healthcare providers, and for tracking interactions between individuals participating in care delivery; Providing on-line non-downloadable software, Software as a Service (SaaS) services, and Platform as a Service (PAAS) featuring software and computer software platforms for administrative, billing, medical, health, and clinical decision support in the field of health care; Providing on-line non-downloadable software , Software as a Service (SaaS) services, and Platform as a Service (PAAS) featuring software and computer software platforms using digital twin technology for analysis and optimization of healthcare workflows and patient health outcomes; Providing on-line non-downloadable software, Software as a Service (SaaS) services, and Platform as a Service (PAAS) featuring software and computer software platforms for tracking operational and performance metrics, and data visualizations in the field of healthcare and providing reports and alerts concerning such performance; Providing on-line nondownloadable software, Software as a Service (SaaS) services, and Platform as a Service (PAAS) featuring software and computer software platforms for management and optimization of healthcare workflows; Providing on-line non-downloadable software, Software as a Service (SaaS) services, and Platform as a Service (PAAS) featuring software and computer software platforms for aggregating healthcare data and resolving interoperability challenges for health providers, payers, and vendors in the healthcare industryACTIVESep 3, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 11, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 11, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 20, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 20, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 21, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 21, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 21, 2025ALIEASSIGNED TO LIE—
Jan 2, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 16, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 16, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 16, 2024CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 4, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 3, 2024IUAFUSE AMENDMENT FILED—
Sep 3, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 29, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 28, 2024EX5GSOU EXTENSION 5 GRANTED—
Mar 28, 2024EXT5SOU EXTENSION 5 FILED—
Mar 28, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 20, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 18, 2023EX4GSOU EXTENSION 4 GRANTED—
Sep 18, 2023EXT4SOU EXTENSION 4 FILED—
Sep 18, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 23, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 21, 2023EX3GSOU EXTENSION 3 GRANTED—
Mar 21, 2023EXT3SOU EXTENSION 3 FILED—
Mar 21, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 19, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 17, 2022EX2GSOU EXTENSION 2 GRANTED—
Aug 17, 2022EXT2SOU EXTENSION 2 FILED—
Aug 17, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 30, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 28, 2022EX1GSOU EXTENSION 1 GRANTED—
Mar 28, 2022EXT1SOU EXTENSION 1 FILED—
Mar 28, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 28, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 3, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 3, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 14, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 28, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 28, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Jun 28, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 28, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 28, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 23, 2021DOCKASSIGNED TO EXAMINER—
Mar 16, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 30, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance